Browsing Tag
medac
2 posts
A $50m quarter changes the stakes for UroGen as UGN-103 reaches FDA
UroGen files UGN-103 with the FDA as ZUSDURI sales surge 73%, potentially extending its fast-growing bladder cancer franchise into 2044.
Medac resubmits treosulfan NDA to FDA, says Medexus Pharmaceuticals
Medexus Pharmaceuticals said that its strategic partner medac has resubmitted the new drug application (NDA) for treosulfan with…